AZILECT
Generic: RASAGILINE MESYLATE, RASAGILINE
Teva NeuroscienceManufacturer
ORALRoute
RASAGILINE MESYLATEActive Substance
2006-05-16Original Approval
AZILECT is FDA application NDA021641, sponsored by TEVA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
HALLUCINATION
468 reports
2
FALL
441 reports
3
DRUG INEFFECTIVE
359 reports
4
DYSKINESIA
337 reports
5
DEATH
294 reports
6
DIZZINESS
292 reports
7
TREMOR
262 reports
8
PARKINSON^S DISEASE
257 reports
9
CONSTIPATION
254 reports
10
GAIT DISTURBANCE
252 reports